European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.44% to 1,292.96 on the S&P Europe Select ADR Index, which is poised to end the week marginally lower.
From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and biopharmaceutical company DBV Technologies (DBVT), which climbed 7.8% and 3.1%, respectively. They were followed by internet advertising company Criteo (CRTO) and telecommunications company VEON (VEON), which rose 3% and 2.6%, respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which fell 6.6% and 4.7%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and brewing company Anheuser-Busch InBev (BUD), which dropped 3.9% and 2%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which increased 4.6% and 4.4%, respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Bicycle Therapeutics (BCYC) which were up 2.9% and 2.8%, respectively.
The decliners from the UK and Ireland were led by alcoholic beverage company Diageo (DEO) and cruise line operator Carnival (CUK), which fell 3% and 2.4%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 2.1% and 1.7%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。